Home Biotech

Biotech

Random

The FDA Has Lifted A Hold on Clinical Trials for an Experimental CymaBay Therapeutics Inc. (NASDAQ:CBAY) Therapeutics Drug; Seladelpar

Max - July 29, 2020

Selos Therapeutics Inc. (NASDAQ: SEEL) Receives FDA Approval For IND To Study SLS-005 in Spinocerebellar Ataxia Treatment

Seattle Genetics Inc. (NASDAQ:SGEN) Enters Two Oncology Collaboration Agreements With Merck (NYSE:MRK)

CRISPR Therapeutics (NASDAQ: CRSP) Provided Updated Data From Study Evaluating CTX110 in r/r CD19+ B-cell Malignancies

MediWound Ltd (NASDAQ: MDWD) Announce $9 Million in Funding From BARDA to Support NexoBrid BLA resubmission

MacroGenics Inc. (NASDAQ:MGNX) Gives Update OnBLA Review for Margetuximab In Treating...

Max - June 4, 2020 0

NanoString Technologies Inc (NASDAQ:NSTG) Gears Up For Its Q3 2020 Earnings...

Max - October 21, 2020 0

Chiasma Inc. (NASDAQ:CHMA) Says OLE data from the 48-week, open-label Phase...

Max - August 14, 2020 0

Tyme Technologies Inc. (NASDAQ: TYME) Receives Patent from USPTO on Claims...

Max - August 3, 2021 0

iBio Inc. (NYSE: IBIO) Signs Licensing Agreement for RTX-003 with RubrYc...

Max - September 6, 2021 0

12 3...354 Page 1 of 354

Recent Post

DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology

Max - January 7, 2025 0

Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...

Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.

January 6, 2025

SciSparc Ltd. (Nasdaq: SPRC): Pioneering Breakthroughs in Central Nervous System Therapies

January 6, 2025

Will stocks rally on the new years eve ?

December 30, 2024

Savara Inc. (SVRA): Progress in Rare Respiratory Disease Treatment with MOLBREEVI

December 30, 2024